VIKING GLOBAL INVESTORS LP 13D and 13G filings for ORIC Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-15 4:35 pm Purchase | 2025-03-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC | VIKING GLOBAL INVESTORS LP | 6,572,700 9.200% | 2,572,700 (+64.32%) | Filing |
| 2024-01-30 4:31 pm Purchase | 2024-01-20 | 13G | ORIC Pharmaceuticals, Inc. ORIC | VIKING GLOBAL INVESTORS LP | 4,000,000 5.900% | 4,000,000 (New Position) | Filing |